123 related articles for article (PubMed ID: 35117943)
1. Evaluation of acute skin toxicity during radiotherapy for breast cancer in elderly patients.
Vieira DS; Reisner ML; Panichella JD; Barbosa IP
Transl Cancer Res; 2020 Jan; 9(Suppl 1):S8-S11. PubMed ID: 35117943
[TBL] [Abstract][Full Text] [Related]
2. Machine-learning prediction model for acute skin toxicity after breast radiation therapy using spectrophotometry.
Cilla S; Romano C; Macchia G; Boccardi M; Pezzulla D; Buwenge M; Castelnuovo AD; Bracone F; Curtis A; Cerletti C; Iacoviello L; Donati MB; Deodato F; Morganti AG
Front Oncol; 2022; 12():1044358. PubMed ID: 36686808
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.
Aluwini S; Pos F; Schimmel E; Krol S; van der Toorn PP; de Jager H; Alemayehu WG; Heemsbergen W; Heijmen B; Incrocci L
Lancet Oncol; 2016 Apr; 17(4):464-474. PubMed ID: 26968359
[TBL] [Abstract][Full Text] [Related]
4. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.
Aluwini S; Pos F; Schimmel E; van Lin E; Krol S; van der Toorn PP; de Jager H; Dirkx M; Alemayehu WG; Heijmen B; Incrocci L
Lancet Oncol; 2015 Mar; 16(3):274-83. PubMed ID: 25656287
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy.
De Santis MC; Bonfantini F; Di Salvo F; Dispinzieri M; Mantero E; Soncini F; Baili P; Sant M; Bianchi G; Maggi C; Di Cosimo S; Agresti R; Pignoli E; Valdagni R; Lozza L
Breast; 2016 Oct; 29():90-5. PubMed ID: 27476083
[TBL] [Abstract][Full Text] [Related]
7. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
[TBL] [Abstract][Full Text] [Related]
8. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer.
Freedman GM; Anderson PR; Li J; Eisenberg DF; Hanlon AL; Wang L; Nicolaou N
Am J Clin Oncol; 2006 Feb; 29(1):66-70. PubMed ID: 16462506
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two radiation boost schedules in postlumpectomy patients with breast cancer.
Yadav BS; Sharma SC; Singh G; Dahiya D
J Cancer Res Ther; 2020; 16(6):1344-1349. PubMed ID: 33342794
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessments of late radiation-induced skin and soft tissue toxicity and correlation with RTOG scales and biological equivalent dose in breast cancer.
Huang Y; Sanz J; Rodríguez N; Duran X; Martínez A; Li X; Foro P; Conde M; Zhao M; Liu F; Reig A; Dengra J; Membrive I; Pérez P; Algara M
Clin Transl Oncol; 2022 May; 24(5):836-845. PubMed ID: 34792726
[TBL] [Abstract][Full Text] [Related]
11. Radiation-induced stress response in peripheral blood of breast cancer patients differs between patients with severe acute skin reactions and patients with no side effects to radiotherapy.
Skiöld S; Naslund I; Brehwens K; Andersson A; Wersall P; Lidbrink E; Harms-Ringdahl M; Wojcik A; Haghdoost S
Mutat Res; 2013 Aug; 756(1-2):152-7. PubMed ID: 23652022
[TBL] [Abstract][Full Text] [Related]
12. Radiation-induced dermatitis among breast cancer patients undergoing adjuvant radiotherapy in Ghana.
Kyei KA; Anim-Sampong S; Akoe EA; Daniels J; Obeng-Mensah T; Antwi WK; Ainuson-Quampah J
Transl Oncol; 2024 Aug; 46():102028. PubMed ID: 38861854
[TBL] [Abstract][Full Text] [Related]
13. Acute supraclavicular skin toxicity in patients undergoing radiotherapy for breast cancer: an evaluation of the 'T'-grip method of patient positioning.
Tho LM; McIntyre A; Rosst A; Gallagher C; Yap C; Ritchie DM; Canney PA
Clin Oncol (R Coll Radiol); 2006 Mar; 18(2):133-8. PubMed ID: 16523814
[TBL] [Abstract][Full Text] [Related]
14. Hypofractionation versus conventional fractionation radiotherapy after conservative treatment of breast cancer: early skin reactions and cosmetic results.
Taher AN; El-Baradie MM; Essa H; Zaki O; Ezzat S
J Egypt Natl Canc Inst; 2004 Sep; 16(3):178-87. PubMed ID: 15959551
[TBL] [Abstract][Full Text] [Related]
15. Differences in the Acute Toxic Effects of Breast Radiotherapy by Fractionation Schedule: Comparative Analysis of Physician-Assessed and Patient-Reported Outcomes in a Large Multicenter Cohort.
Jagsi R; Griffith KA; Boike TP; Walker E; Nurushev T; Grills IS; Moran JM; Feng M; Hayman J; Pierce LJ
JAMA Oncol; 2015 Oct; 1(7):918-30. PubMed ID: 26247417
[TBL] [Abstract][Full Text] [Related]
16. A unique hypofractionated radiotherapy schedule with 51.3 Gy in 18 fractions three times per week for early breast cancer: outcomes including local control, acute and late skin toxicity.
Vassilis K; Ioannis G; Anna Z; Christina A; Christos A; John K; Porfyrios K; Vassiliki G; John K
Breast Cancer; 2017 Mar; 24(2):263-270. PubMed ID: 27093861
[TBL] [Abstract][Full Text] [Related]
17. Accelerated hypofractionated adjuvant whole breast radiation with simultaneous integrated boost using volumetric modulated arc therapy for early breast cancer: A phase I/II dosimetric and clinical feasibility study from a tertiary cancer care centre of India.
Mondal D; Julka PK; Sharma DN; Jana M; Laviraj MA; Deo SV; Roy S; Guleria R; Rath GK
J Egypt Natl Canc Inst; 2017 Mar; 29(1):39-45. PubMed ID: 28343538
[TBL] [Abstract][Full Text] [Related]
18. Toxicity and cosmetic outcome of hypofractionated whole-breast radiotherapy: predictive clinical and dosimetric factors.
Ciammella P; Podgornii A; Galeandro M; Micera R; Ramundo D; Palmieri T; Cagni E; Iotti C
Radiat Oncol; 2014 Apr; 9():97. PubMed ID: 24762173
[TBL] [Abstract][Full Text] [Related]
19. The impact of skin washing with water and soap during breast irradiation: a randomized study.
Roy I; Fortin A; Larochelle M
Radiother Oncol; 2001 Mar; 58(3):333-9. PubMed ID: 11230896
[TBL] [Abstract][Full Text] [Related]
20. Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Brand DH; Tree AC; Ostler P; van der Voet H; Loblaw A; Chu W; Ford D; Tolan S; Jain S; Martin A; Staffurth J; Camilleri P; Kancherla K; Frew J; Chan A; Dayes IS; Henderson D; Brown S; Cruickshank C; Burnett S; Duffton A; Griffin C; Hinder V; Morrison K; Naismith O; Hall E; van As N;
Lancet Oncol; 2019 Nov; 20(11):1531-1543. PubMed ID: 31540791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
